ICM
JSPR icon

Ionic Capital Management’s Jasper Therapeutics JSPR Stock Holding History

Ionic Capital Management’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10
Closed – – 398
2022
Q3 		$0 Buy
+10
New +$183 ﹤0.01% 492
2022
Q2 		– Sell
-10
Closed – – 472
2022
Q1 		$0 Hold
10
– – ﹤0.01% 466
2021
Q4 		$1K Buy
+10
New +$936 ﹤0.01% 374

Other funds holding JSPR

QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FIM
Fernwood Investment Management Quincy, Massachusetts $288M AUM 33.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ionic Capital Management's JSPR Position: Q4 2022 in Review

Ionic Capital Management sold out of Jasper Therapeutics (JSPR) in Q4 2022, closing a stake of 10 shares.

Ionic Capital Management first reported a position in JSPR in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q4 2021. 22 funds tracked by Wall St. Rank hold JSPR as of Q4 2022.

  • Ionic Capital Management reported no remaining Jasper Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Ionic Capital Management sold 10 Jasper Therapeutics shares in Q4 2022.
  • Ionic Capital Management first reported a position in Jasper Therapeutics in Q4 2021 and held it in 3 quarters.
  • Ionic Capital Management's Jasper Therapeutics position peaked at $1K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q4 2022.

Based on Ionic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.